AI Science Tracker
EN

Department of Pathology

2 discoveries from 2021 to 2026

Discoveries

Pathomics-based machine learning models for predicting METTL5 expression and prognosis in lung adenocarcinoma.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: The primary full text supports the case-specific result: Pathomics models predicted METTL5 expression and prognosis in lung adenocarcinoma with validation performance.

Technology: Methods identify the case-specific learned operation: Pathomics models predicted METTL5 expression and prognosis in lung adenocarcinoma with validation performance.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Methods identify the case-specific learned operation: Pathomics models predicted METTL5 expression and prognosis in lung adenocarcinoma with validation performance.
Limitation / still unknown
The full text reports the case-specific data/cohort, comparison/reference and evaluation; no broader clinical benefit is inferred.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13559335/ · https://pubmed.ncbi.nlm.nih.gov/42724470/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy.

Source check: Source checked. Not independent scientific confirmation.

Finding: The trained Paige Prostate classifier scores whole-slide biopsy images against separately rendered pathology diagnoses. A 1,876-image independent-institution cohort and pathologist review of discrepancies support external diagnostic validation; poor-quality scans remain a limitation. The paper appeared in Modern Pathology. Organization is unavailable in the deposited bibliographic metadata.

Technology: Paige Prostate whole-slide image classifier

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
The trained Paige Prostate classifier scores whole-slide biopsy images against separately rendered pathology diagnoses.
Test and result
The trained Paige Prostate classifier scores whole-slide biopsy images against separately rendered pathology diagnoses. A 1,876-image independent-institution cohort and pathologist review of discrepancies support external diagnostic validation; poor-quality scans remain a limitation.
Limitation / still unknown
A 1,876-image independent-institution cohort and pathologist review of discrepancies support external diagnostic validation; poor-quality scans remain a limitation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8295034/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.